<?xml version="1.0" encoding="UTF-8"?>
<p>Early detection, prevention, and treatment of complications caused by chronic HCV infection may improve the outcomes of infected kidney transplant recipients [
 <xref rid="B16" ref-type="bibr">16</xref>]. Screening for HCV infection is done using a serological assay that detects antibodies against HCV (anti-HCV). After a positive anti-HCV test, HCV RNA testing should be performed. A negative result is considered a resolved HCV infection (or a false-positive antibody test) [
 <xref rid="B17" ref-type="bibr">17</xref>].
</p>
